Emerging role of leptin in rheumatoid arthritis.

PubWeight™: 0.82‹?›

🔗 View Article (PMC 4137840)

Published in Clin Exp Immunol on September 01, 2014

Authors

G Tian1, J-N Liang, Z-Y Wang, D Zhou

Author Affiliations

1: School of Health Management, Anhui Medical University, Hefei, Anhui, China.

Articles cited by this

(truncated to the top 100)

Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell (2000) 7.87

Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature (1998) 7.36

Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation (2003) 4.52

Leptin regulates proinflammatory immune responses. FASEB J (1998) 4.31

Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial. Arthritis Rheum (2002) 3.78

A key role of leptin in the control of regulatory T cell proliferation. Immunity (2007) 3.71

Evidence for a key role of leptin in osteoarthritis. Arthritis Rheum (2003) 3.66

Activation of downstream signals by the long form of the leptin receptor. J Biol Chem (2000) 3.52

AMPK is essential for energy homeostasis regulation and glucose sensing by POMC and AgRP neurons. J Clin Invest (2007) 3.32

The weight of leptin in immunity. Nat Rev Immunol (2004) 3.24

Forkhead protein FoxO1 mediates Agrp-dependent effects of leptin on food intake. Nat Med (2006) 3.24

Protein kinase C isozymes and the regulation of diverse cell responses. Am J Physiol Lung Cell Mol Physiol (2000) 3.13

Leptin receptor signaling and the regulation of mammalian physiology. Recent Prog Horm Res (2004) 2.67

Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. Endocrinology (1999) 2.65

Adiponectin as an anti-inflammatory factor. Clin Chim Acta (2007) 2.56

SOCS3 mediates feedback inhibition of the leptin receptor via Tyr985. J Biol Chem (2000) 2.41

Recent advances in understanding leptin signaling and leptin resistance. Am J Physiol Endocrinol Metab (2009) 2.27

Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis. Ann Rheum Dis (2006) 2.25

Crystal structure of the obese protein leptin-E100. Nature (1997) 2.22

Regulated expression of the obese gene product (leptin) in white adipose tissue and 3T3-L1 adipocytes. Proc Natl Acad Sci U S A (1995) 2.17

Leptin is expressed in and secreted from primary cultures of human osteoblasts and promotes bone mineralization. J Bone Miner Res (2001) 2.15

Leptin regulation of the immune response and the immunodeficiency of malnutrition. FASEB J (2001) 2.12

Divergent roles of SHP-2 in ERK activation by leptin receptors. J Biol Chem (2000) 1.99

Leptin: a pivotal mediator of intestinal inflammation in mice. Gastroenterology (2002) 1.96

Leptin signaling deficiency impairs humoral and cellular immune responses and attenuates experimental arthritis. J Immunol (2002) 1.95

Leptin, from fat to inflammation: old questions and new insights. FEBS Lett (2005) 1.92

Role of leptin in the activation of immune cells. Mediators Inflamm (2010) 1.84

Body mass index, leptin and leptin receptor polymorphisms, and non-hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev (2004) 1.80

Leptin promotes invasiveness of kidney and colonic epithelial cells via phosphoinositide 3-kinase-, rho-, and rac-dependent signaling pathways. FASEB J (2000) 1.75

High-dose leptin activates human leukocytes via receptor expression on monocytes. J Immunol (2001) 1.74

Hyperleptinemia and reduced TNF-alpha secretion cause resistance of db/db mice to endotoxin. Am J Physiol Regul Integr Comp Physiol (2003) 1.71

Role of leptin in immunity. Cell Mol Immunol (2007) 1.67

Role of leptin as an immunomodulator of blood mononuclear cells: mechanisms of action. Clin Exp Immunol (2003) 1.65

What's new in our understanding of the role of adipokines in rheumatic diseases? Nat Rev Rheumatol (2011) 1.63

Leptin signalling. Cell Signal (2002) 1.63

Leptin-induced signal transduction pathways. Cell Biol Int (2004) 1.53

The long form of the leptin receptor regulates STAT5 and ribosomal protein S6 via alternate mechanisms. J Biol Chem (2007) 1.53

The Q223R polymorphism of the leptin receptor gene is significantly associated with obesity and predicts a small percentage of body weight and body composition variability. J Clin Endocrinol Metab (2001) 1.52

Leptin signaling in the hypothalamus: emphasis on energy homeostasis and leptin resistance. Front Neuroendocrinol (2003) 1.50

Systemic blockade of TNF-α does not improve insulin resistance in humans. Horm Metab Res (2011) 1.48

Signalling pathway involved in nitric oxide synthase type II activation in chondrocytes: synergistic effect of leptin with interleukin-1. Arthritis Res Ther (2005) 1.47

Adipocytokines are associated with radiographic joint damage in rheumatoid arthritis. Arthritis Rheum (2009) 1.45

Elevated serum leptin levels in nonobese patients with psoriasis. J Drugs Dermatol (2013) 1.44

Serum leptin levels in women with systemic lupus erythematosus. Rheumatol Int (2002) 1.42

Leptin promotes differentiation and survival of human dendritic cells and licenses them for Th1 priming. J Immunol (2005) 1.42

Human articular chondrocytes express functional leptin receptors. Biochem Biophys Res Commun (2001) 1.41

Resistin in rheumatoid arthritis synovial tissue, synovial fluid and serum. Ann Rheum Dis (2006) 1.40

Leptin receptor (OB-R) signaling. Cytoplasmic domain mutational analysis and evidence for receptor homo-oligomerization. J Biol Chem (1997) 1.38

Leptin consumption in the inflamed joints of patients with rheumatoid arthritis. Ann Rheum Dis (2003) 1.38

Markers of inflammation are negatively correlated with serum leptin in rheumatoid arthritis. Ann Rheum Dis (2005) 1.35

Osteoblasts and bone formation. Acta Reumatol Port (2007) 1.34

Leptin serum levels are not correlated with disease activity in patients with rheumatoid arthritis. Metabolism (1999) 1.33

Adiponectin is a mediator of the inverse association of adiposity with radiographic damage in rheumatoid arthritis. Arthritis Rheum (2009) 1.30

Synergistic induction of nitric oxide synthase type II: in vitro effect of leptin and interferon-gamma in human chondrocytes and ATDC5 chondrogenic cells. Arthritis Rheum (2003) 1.29

Leptin directly induces the secretion of interleukin 1 receptor antagonist in human monocytes. J Clin Endocrinol Metab (2001) 1.27

Leptin produced by joint white adipose tissue induces cartilage degradation via upregulation and activation of matrix metalloproteinases. Ann Rheum Dis (2011) 1.25

Leptin requires canonical migratory signaling pathways for induction of monocyte and macrophage chemotaxis. Am J Physiol Cell Physiol (2007) 1.25

Leptin receptor activation of SH2 domain containing protein tyrosine phosphatase 2 modulates Ob receptor signal transduction. Proc Natl Acad Sci U S A (1999) 1.23

Serum level of adiponectin is a surrogate independent biomarker of radiographic disease progression in early rheumatoid arthritis: results from the ESPOIR cohort. Arthritis Res Ther (2013) 1.22

Expression of leptin receptors and response to leptin stimulation of human natural killer cell lines. Biochem Biophys Res Commun (2003) 1.21

Mapping of the leptin binding sites and design of a leptin antagonist. J Biol Chem (2004) 1.19

Anti-TNF-alpha therapy does not modulate leptin in patients with severe rheumatoid arthritis. Clin Exp Rheumatol (2009) 1.17

Leptin regulates functional capacities of polymorphonuclear neutrophils. Free Radic Res (2003) 1.10

Development of leptin antagonists and their potential use in experimental biology and medicine. Trends Endocrinol Metab (2006) 1.10

Involvement of leptin signaling in the survival and maturation of bone marrow-derived dendritic cells. Eur J Immunol (2006) 1.10

Infliximab therapy increases body fat mass in early rheumatoid arthritis independently of changes in disease activity and levels of leptin and adiponectin: a randomised study over 21 months. Arthritis Res Ther (2010) 1.09

Subcellular localization and internalization of the four human leptin receptor isoforms. J Biol Chem (1999) 1.09

Association of circulating adiponectin levels with progression of radiographic joint destruction in rheumatoid arthritis. Ann Rheum Dis (2011) 1.08

Comparison of rheumatoid articular adipose and synovial tissue reactivity to proinflammatory stimuli: contribution to adipocytokine network. Ann Rheum Dis (2011) 1.06

Leptin activates human B cells to secrete TNF-α, IL-6, and IL-10 via JAK2/STAT3 and p38MAPK/ERK1/2 signaling pathway. J Clin Immunol (2011) 1.05

Leptin signaling in human peripheral blood mononuclear cells, activation of p38 and p42/44 mitogen-activated protein (MAP) kinase and p70 S6 kinase. Mol Cell Biol Res Commun (2000) 1.04

An extensive phenotypic characterization of the hTNFalpha transgenic mice. BMC Physiol (2007) 1.04

Leptin-mediated activation of human platelets: involvement of a leptin receptor and phosphodiesterase 3A-containing cellular signaling complex. Am J Physiol Endocrinol Metab (2005) 1.03

Regulatory CD4 T cells: sensing the environment. Trends Immunol (2007) 1.03

Induction of neutrophil chemotaxis by leptin: crucial role for p38 and Src kinases. Ann N Y Acad Sci (2006) 1.02

Glucocorticoid-induced osteopenia in the mouse as assessed by histomorphometry, microcomputed tomography, and biochemical markers. Bone (2002) 1.01

Leptin-mediated cytokine release and migration of eosinophils: implications for immunopathophysiology of allergic inflammation. Eur J Immunol (2007) 0.99

Nuclear translocation of the transcription factor STAT5 in the rat brain after systemic leptin administration. Neurosci Lett (2007) 0.99

Leptin serum levels in rheumatoid arthritis patients: relation to disease duration and activity. Rheumatol Int (2007) 0.98

No change of serum levels of leptin and adiponectin during anti-tumour necrosis factor antibody treatment with adalimumab in patients with rheumatoid arthritis. Ann Rheum Dis (2006) 0.97

Relationship between growth hormone-IGF-I-IGFBP-3 axis and serum leptin levels with bone mass and body composition in patients with rheumatoid arthritis. Rheumatology (Oxford) (2004) 0.97

Leptin induces CD40 expression through the activation of Akt in murine dendritic cells. J Biol Chem (2007) 0.97

Serum leptin in systemic lupus erythematosus. Rheumatol Int (2008) 0.97

Elevated serum levels of resistin, leptin, and adiponectin are associated with C-reactive protein and also other clinical conditions in rheumatoid arthritis. Intern Med (2011) 0.97

Leptin as a metabolic link to multiple sclerosis. Nat Rev Neurol (2010) 0.96

Leptin and mucosal immunity. Mucosal Immunol (2012) 0.96

Jak/STAT/SOCS signaling circuits and associated cytokine-mediated inflammation and hypertrophy in the heart. Shock (2006) 0.96

Adipokines, inflammation, insulin resistance, and carotid atherosclerosis in patients with rheumatoid arthritis. Arthritis Res Ther (2013) 0.95

Synovial/serum leptin ratio in rheumatoid arthritis: the association with activity and erosion. Rheumatol Int (2010) 0.94

Estrogen receptor alpha gene polymorphisms Pvu II and Xba I influence association between leptin receptor gene polymorphism (Gln223Arg) and bone mineral density in young men. Eur J Endocrinol (2002) 0.94

Are plasma and synovial fluid leptin levels correlated with disease activity in rheumatoid arthritis ? Rheumatol Int (2006) 0.93

Leptin inhibits apoptosis in thymus through a janus kinase-2-independent, insulin receptor substrate-1/phosphatidylinositol-3 kinase-dependent pathway. Endocrinology (2006) 0.93

Leptin in septic arthritis: decreased levels during infection and amelioration of disease activity upon its administration. Arthritis Res (2001) 0.92

Serum and synovial fluid leptin levels and markers of inflammation in rheumatoid arthritis. Rheumatol Int (2008) 0.91

Adiponectin and leptin induce VCAM-1 expression in human and murine chondrocytes. PLoS One (2012) 0.91

Obesity and osteoarthritis: is leptin the link? Arthritis Rheum (2009) 0.90

Identification of a monoclonal antibody against the leptin receptor that acts as an antagonist and blocks human monocyte and T cell activation. J Immunol Methods (2006) 0.90

Serum leptin levels in rheumatoid arthritis and relationship with disease activity. South Med J (2006) 0.89

Tumour necrosis factor-alpha exerts dual effects on human adipose leptin synthesis and release. Mol Cell Endocrinol (2000) 0.89

Leptin in immuno-rheumatological diseases. Cell Mol Immunol (2011) 0.89

Articles by these authors

(truncated to the top 100)

Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood (1996) 5.31

Association of genetic variation in FTO with risk of obesity and type 2 diabetes with data from 96,551 East and South Asians. Diabetologia (2011) 2.37

Epidemiological link between exposure to poultry and all influenza A(H7N9) confirmed cases in Huzhou city, China, March to May 2013. Euro Surveill (2013) 2.34

Homing receptors and vascular addressins: cell adhesion molecules that direct lymphocyte traffic. Immunol Rev (1989) 2.06

Migration of dendritic cells in response to formyl peptides, C5a, and a distinct set of chemokines. J Immunol (1995) 2.06

Acute toxicity and n-octanol/water partition coefficients of substituted thiophenols: determination and QSAR analysis. Ecotoxicol Environ Saf (2011) 2.04

Receptor expression and responsiveness of human dendritic cells to a defined set of CC and CXC chemokines. J Immunol (1997) 2.02

Monitoring the brain: processed electroencephalogram and peri-operative outcomes. Anaesthesia (2014) 2.02

Induction of natural killer cell migration by monocyte chemotactic protein-1, -2 and -3. Eur J Immunol (1994) 2.01

Striking a balance: modulation of the actin cytoskeleton by Salmonella. Proc Natl Acad Sci U S A (2000) 1.89

Statistical analysis of MPSS measurements: application to the study of LPS-activated macrophage gene expression. Proc Natl Acad Sci U S A (2005) 1.84

Causes of death among people with convulsive epilepsy in rural West China: a prospective study. Neurology (2011) 1.77

Repeated embolism and multiple aneurysms: central nervous system manifestations of cardiac myxoma. Eur J Neurol (2008) 1.72

T cell receptor V beta repertoire in an acute infection of rhesus monkeys with simian immunodeficiency viruses and a chimeric simian-human immunodeficiency virus. J Exp Med (1995) 1.61

Clinical features of convulsive status epilepticus: a study of 220 cases in western China. Eur J Neurol (2009) 1.53

Mst1/2 signalling to Yap: gatekeeper for liver size and tumour development. Br J Cancer (2010) 1.53

The pathogenesis of gonococcal urethritis in men: confocal and immunoelectron microscopic analysis of urethral exudates from men infected with Neisseria gonorrhoeae. J Infect Dis (1996) 1.52

In vivo crypt surface hyperproliferation is decreased by butyrate and increased by deoxycholate in normal rat colon: associated in vivo effects on c-Fos and c-Jun expression. JPEN J Parenter Enteral Nutr (1997) 1.50

Normalization of diabetes in spontaneously diabetic cynomologus monkeys by xenografts of microencapsulated porcine islets without immunosuppression. J Clin Invest (1996) 1.50

Nervous system defects of AnkyrinB (-/-) mice suggest functional overlap between the cell adhesion molecule L1 and 440-kD AnkyrinB in premyelinated axons. J Cell Biol (1998) 1.43

Receptors and transduction pathways for monocyte chemotactic protein-2 and monocyte chemotactic protein-3. Similarities and differences with MCP-1. J Immunol (1994) 1.42

A new nude mouse model for postmenopausal breast cancer using MCF-7 cells transfected with the human aromatase gene. Cancer Res (1994) 1.39

A positive feedback loop of ER-α36/EGFR promotes malignant growth of ER-negative breast cancer cells. Oncogene (2010) 1.33

Homozygous delta 32 deletion of the CCR-5 chemokine receptor gene in an HIV-1-infected patient. AIDS (1997) 1.32

Adult carotid chemoafferent responses to hypoxia after 1, 2, and 4 wk of postnatal hyperoxia. J Appl Physiol (1985) (2003) 1.30

Lack of the p50 subunit of nuclear factor-kappaB increases the vulnerability of hippocampal neurons to excitotoxic injury. J Neurosci (1999) 1.30

Adenosine A3 receptor expression and function in eosinophils. Am J Respir Cell Mol Biol (1997) 1.28

Immunohistochemical localization of the D1 dopamine receptor in rat brain reveals its axonal transport, pre- and postsynaptic localization, and prevalence in the basal ganglia, limbic system, and thalamic reticular nucleus. Proc Natl Acad Sci U S A (1992) 1.27

Effect of exogenous sialylation of the lipooligosaccharide of Neisseria gonorrhoeae on opsonophagocytosis. Infect Immun (1992) 1.24

Pivotal role for acidic sphingomyelinase in cerebral ischemia-induced ceramide and cytokine production, and neuronal apoptosis. J Mol Neurosci (2000) 1.22

Role of stress-activated mitogen-activated protein kinase (p38) in beta 2-integrin-dependent neutrophil adhesion and the adhesion-dependent oxidative burst. J Immunol (1998) 1.21

Immune biology of macaque lymphocyte populations during mycobacterial infection. Clin Exp Immunol (2003) 1.20

Apparent genetic redundancy facilitates ecological plasticity for nitrate transport. EMBO J (2001) 1.18

Antiretroviral agents restore Mycobacterium-specific T-cell immune responses and facilitate controlling a fatal tuberculosis-like disease in Macaques coinfected with simian immunodeficiency virus and Mycobacterium bovis BCG. J Virol (2001) 1.17

Expression of adhesion molecules, platelet-activating factor, and chemokines by Kaposi's sarcoma cells. J Immunol (1994) 1.15

Modulation of aromatase expression in the breast tissue by ERR alpha-1 orphan receptor. Cancer Res (1998) 1.15

Haloperidol concentrations elevated in Chinese patients. Psychiatry Res (1984) 1.14

Elliptic flow of charged particles in Pb-Pb collisions at sqrt[S(NN)] = 2.76 TeV. Phys Rev Lett (2010) 1.12

Biosynthesis of the linkage region of glycosaminoglycans: cloning and activity of galactosyltransferase II, the sixth member of the beta 1,3-galactosyltransferase family (beta 3GalT6). J Biol Chem (2001) 1.12

A new monoclonal antibody (5D3-F7) which recognizes human monocyte-chemotactic protein-1 but not related chemokines. Development of a sandwich ELISA and in situ detection of producing cells. J Immunol Methods (1994) 1.12

Particle-yield modification in jetlike azimuthal dihadron correlations in Pb-Pb collisions at √s(NN)=2.76 TeV. Phys Rev Lett (2012) 1.11

Aromatase gene expression and its exon I usage in human breast tumors. Detection of aromatase messenger RNA by reverse transcription-polymerase chain reaction. J Steroid Biochem Mol Biol (1996) 1.11

Altered ligand binding and transcriptional regulation by mutations in the PML/RARalpha ligand-binding domain arising in retinoic acid-resistant patients with acute promyelocytic leukemia. Blood (2000) 1.11

Tn916-generated, lipooligosaccharide mutants of Neisseria meningitidis and Neisseria gonorrhoeae. Infect Immun (1994) 1.10

Autocrine and paracrine actions of breast tumor aromatase. A three-dimensional cell culture study involving aromatase transfected MCF-7 and T-47D cells. J Steroid Biochem Mol Biol (1998) 1.09

Microheterogeneity of Neisseria lipooligosaccharide: analysis of a UDP-glucose 4-epimerase mutant of Neisseria meningitidis NMB. Infect Immun (1995) 1.09

Multiple matching scheme for broadband 0.72Pb(Mg(13)Nb(23))O(3)-0.28PbTiO(3) single crystal phased-array transducer. J Appl Phys (2009) 1.08

Transverse momentum distribution and nuclear modification factor of charged particles in p+Pb collisions at sqrt[s(NN)] = 5.02 TeV. Phys Rev Lett (2013) 1.08

Cytokine gene expression in B-cell chronic lymphocytic leukemia: evidence of constitutive interleukin-8 (IL-8) mRNA expression and secretion of biologically active IL-8 protein. Blood (1994) 1.07

Targeted deletion of the lipopolysaccharide (LPS)-binding protein gene leads to profound suppression of LPS responses ex vivo, whereas in vivo responses remain intact. J Exp Med (1997) 1.06

Cyclic nucleotide phosphodiesterase type IV participates in the regulation of IL-10 and in the subsequent inhibition of TNF-alpha and IL-6 release by endotoxin-stimulated macrophages. J Immunol (1995) 1.06

Higher harmonic anisotropic flow measurements of charged particles in Pb-Pb collisions at sqrt(s(NN)) = 2.76  TeV. Phys Rev Lett (2011) 1.05

Beta-subunit-dependent modulation of hSlo BK current by arachidonic acid. J Neurophysiol (2006) 1.04

Expiratory neural activities in gasping. J Appl Physiol (1985) (1989) 1.04

Protein farnesyltransferase in plants: molecular characterization and involvement in cell cycle control. Plant Cell (1996) 1.04

Binding characteristics of seven inhibitors of human aromatase: a site-directed mutagenesis study. Cancer Res (1996) 1.03

Leukemia inhibitory factor (LIF) and LIF receptor in human lung. Distribution and regulation of LIF release. Am J Respir Cell Mol Biol (1999) 1.02

Differing control of neural activities during various portions of expiration in the cat. J Physiol (1989) 1.02

Substance P (NK1)- and neurokinin A (NK2)-receptor gene expression in inflammatory airway diseases. Am J Physiol (1995) 1.01

Different signaling pathways for CD18-mediated adhesion and Fc-mediated phagocytosis. Response of neutrophils to LPS. J Immunol (1994) 1.01

XRCC1 Arg399Gln and Arg194Trp polymorphisms in prostate cancer risk: a meta-analysis. Prostate Cancer Prostatic Dis (2011) 1.00

Designing small-molecule switches for protein-protein interactions. Science (2000) 0.99

Cloning of a mouse beta 1,3 N-acetylglucosaminyltransferase GlcNAc(beta 1,3)Gal(beta 1,4)Glc-ceramide synthase gene encoding the key regulator of lacto-series glycolipid biosynthesis. J Biol Chem (2001) 0.99

Acupuncture for Bell's palsy. Cochrane Database Syst Rev (2007) 0.99

Incidence, management and mortality of acute hypoxemic respiratory failure and acute respiratory distress syndrome from a prospective study of Chinese paediatric intensive care network. Acta Paediatr (2010) 0.98

Production of muons from heavy flavor decays at forward rapidity in pp and Pb-Pb collisions at sqrt[s(NN)]=2.76  TeV. Phys Rev Lett (2012) 0.98

Isolation and characterization of root-specific phosphate transporter promoters from Medicago trunatula. Plant Biol (Stuttg) (2006) 0.98

Interleukin-12 is chemotactic for natural killer cells and stimulates their interaction with vascular endothelium. Blood (1994) 0.98

"Helicobacter heilmannii" infection in a patient with gastric cancer. Dig Dis Sci (1995) 0.97

Cytoskeletal disruption accelerates caspase-3 activation and alters the intracellular membrane reorganization in DNA damage-induced apoptosis. Exp Cell Res (2000) 0.97

Acquisition of intact allogeneic human leukocyte antigen molecules by human dendritic cells. Blood (2000) 0.97

Molecular basis for the constitutive activity of estrogen-related receptor alpha-1. J Biol Chem (2001) 0.97

Direct sequencing analysis of exon 1 of the c-K-ras gene shows a low frequency of mutations in human pancreatic adenocarcinomas. Oncogene (1989) 0.97

Nonopsonic phagocytosis of group C Neisseria meningitidis by human neutrophils. Infect Immun (1998) 0.96

The relationship of fluorosis and brick tea drinking in Chinese Tibetans. Environ Health Perspect (1996) 0.96

A high-resolution chemical and structural study of framboidal pyrite formed within a low-temperature bacterial biofilm. Geobiology (2008) 0.96

Life-long impairment of hypoxic phrenic responses in rats following 1 month of developmental hyperoxia. J Physiol (2002) 0.96

Oxidative stress and vanadate induce tyrosine phosphorylation of phosphoinositide-dependent kinase 1 (PDK1). Biochemistry (2000) 0.96

Rapid induction of arachidonic acid release by monocyte chemotactic protein-1 and related chemokines. Role of Ca2+ influx, synergism with platelet-activating factor and significance for chemotaxis. J Biol Chem (1994) 0.96

Neuroprotective role for the p50 subunit of NF-kappaB in an experimental model of Huntington's disease. J Mol Neurosci (2000) 0.96

Daunorubicin uptake by leukemic cells: correlations with treatment outcome and mdr1 expression. Leukemia (1993) 0.96

Molecular basis of the catalytic differences among DT-diaphorase of human, rat, and mouse. J Biol Chem (1997) 0.95

Modulation of aromatase expression in human breast tissue. J Steroid Biochem Mol Biol (2001) 0.95

Receptors, signal transduction, and spectrum of action of monocyte chemotactic protein-1 and related chemokines. J Leukoc Biol (1995) 0.94

Endotoxin receptors (CD14) are found with CD16 (Fc gamma RIII) in an intracellular compartment of neutrophils that contains alkaline phosphatase. J Immunol (1995) 0.94

Stimulating properties of 5-oxo-eicosanoids for human monocytes: synergism with monocyte chemotactic protein-1 and -3. J Immunol (1996) 0.94

The sodium-activated potassium channel Slack is modulated by hypercapnia and acidosis. Neuroscience (2007) 0.94

Centrality dependence of the charged-particle multiplicity density at midrapidity in Pb-Pb collisions at sqrt[s(NN)] = 2.76 TeV. Phys Rev Lett (2011) 0.93

Breast tumor aromatase: functional role and transcriptional regulation. Endocr Relat Cancer (1999) 0.92

High frequency PMN-PT single crystal focusing transducer fabricated by a mechanical dimpling technique. Ultrasonics (2012) 0.91

Modulation of nerve growth factor in peripheral organs by estrogen and progesterone. Neuroscience (2002) 0.91

Unrelated cord blood transplantation for newly diagnosed patients with severe acquired aplastic anemia using a reduced-intensity conditioning: high graft rejection, but good survival. Bone Marrow Transplant (2012) 0.91

In vivo T-lymphocyte activation and transient reduction of viral replication in macaques infected with simian immunodeficiency virus. J Virol (2001) 0.91

Functional domains of aromatase cytochrome P450 inferred from comparative analyses of amino acid sequences and substantiated by site-directed mutagenesis experiments. J Biol Chem (1992) 0.90

Association between carbamazepine-induced cutaneous adverse drug reactions and the HLA-B*1502 allele among patients in central China. Epilepsy Behav (2010) 0.90

Leukemia inhibitory factor is synthesized and released by human eosinophils and modulates activation state and chemotaxis. J Allergy Clin Immunol (1999) 0.90

IL-1 beta primes IL-8-activated human neutrophils for elastase release, phospholipase D activity, and calcium flux. J Leukoc Biol (1996) 0.90

Synergism between platelet activating factor and C-C chemokines for arachidonate release in human monocytes. Biochem Biophys Res Commun (1994) 0.89

Effect of androstenedione on growth of untransfected and aromatase-transfected MCF-7 cells in culture. J Steroid Biochem Mol Biol (1993) 0.89

Discharge of vagal pulmonary receptors differentially alters neural activities during various stages of expiration in the cat. J Physiol (1990) 0.89